SYK
-
Devices & Diagnostics, Hospitals
Stryker mimics Medtronic in move to buy Chinese orthopedics maker for $764M
They say imitation is the best form of flattery. In announcing that it was buying […]
-
Devices & Diagnostics, Hospitals
Stryker CEO says firm’s foot and ankle business is taking on likes of Wright Medical & Arthrex
The 75 direct sales force dedicated to boost Stryker’s (NYSE: SYK) foot and ankle business unit […]
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Stryker’s new CEO: Innovation teams now asking, “Who is going to pay for this?”
Just one month ago, Kevin Lobo took over the top spot at medical device maker […]
-
Stryker announces FDA approval of clot removal device to treat ischemic stroke
Stryker announced Monday that the U.S. Food and Drug Administration has cleared a clot removal […]
-
Synthes suit accuses Stryker of stealing trade secrets
Synthes is back in court, this time as the plaintiff in a lawsuit against Stryker […]
-
Devices & Diagnostics, MedCity Influencers
Stryker sales drop 3 percent, shares follow
Stryker Corp.’s (NYSE:SYK) second-quarter sales slid more than 3 percent, despite a top-line rise of […]
-
Devices & Diagnostics, MedCity Influencers
Stryker wins deals for joint preservation, spine medical devices
Stryker Corp. (NYSE:SYK) inked new deals for its joint preservation arm and its interventional spine […]
-
Devices & Diagnostics, MedCity Influencers
Stryker Spine faces two new lawsuits
Stryker Corp. (NYSE:SYK) is fielding legal challenges on two fronts, one from a former distributor […]
-
Stryker orthopedics division head moves to DJO Global
Michael Mogul, the head of Stryker Corp.’s (NYSE:SYK) $4-billion-plus orthopedics division, is off to greener […]
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Devices & Diagnostics, MedCity Influencers
Stryker buyout? Not if Orthovita shareholders can stop it.
Shareholders of Orthovita Inc. (NSDQ: VITA), a Malvern, Pa.-based orthopedic biologics maker, are suing over […]
-
Devices & Diagnostics, MedCity Influencers
Orthopedic industry struggles won’t defeat Stryker, CEO says
Stryker Corp. (NYSE: SYK ) CEO Stephen MacMillan took time out to tout his company’s […]
-
Devices & Diagnostics, MedCity Influencers
Stryker CEO defers his pay raise again
Stryker Corp. CEO Stephen MacMillan ceded another pay raise last year, citing the “challenging business […]
-
Devices & Diagnostics, MedCity Influencers
Stryker Biotech responds to government lawsuit over bone-growth products
The Stryker lawsuit claims the company improperly promoted off-label use of a pair of bone-growth products and also lied to the Food & Drug Administration. Stryker Biotech now says the government is over-reaching with its indictment and failing to back up most of its charges.
-
Stryker selling controversial bone growth line for $60M
Orthopedics company Stryker Corp. (NYSE:SYK) has agreed to sell a product line including the bone growth putty that has caused the company so much legal grief to Olympus Corp. for $60 million. Kalamazoo, Michigan-based Stryker plans to record a loss on the sale of its OP-1 product line of between $75 million and $80 million.
-
Bet on St. Jude Medical, not Boston Scientific, stock watchers say
I’ve devoted plenty of Internet ink to the diverging fortunes of St. Jude Medical Inc. (NYSE:STJ) and Boston Scientific Corp. (NYSE:BSX). Apparently other people see the same thing.